Alvotech stock is traded at $4.55, with a volume of 753,748. It is down -2.57% in the last 24 hours and down -25.53% over the past month. Alvotech is a biopharmaceutical company focused solely on the development and manufacture of biosimilar medicines for patients globally. Its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases. The company's commercialized products incldue AVT02, AVT03, AVT04, AVT05, and AVT06. Its pipeline contains eight biosimilar candidates aimed at treating autoimmune disorders, eye disorders, osteoporosis, and cancer. Geographically, the company generates the majority of revenue from Europe, and the rest from the USA and the rest of the world.
Previous Close:
$4.67
Open:
$4.66
24h Volume:
753,748
Relative Volume:
1.04
Market Cap:
$1.62B
Revenue:
$563.46M
Net Income/Loss:
$27.92M
P/E Ratio:
47.20
EPS:
$0.0964
Net Cash Flow:
-$146.33M
1W Performance:
-6.95%
1M Performance:
-25.53%
6M Performance:
+30.00%
1Y Performance:
-6.76%
1-Day Range:
$4.51$4.66
1-Week Range:
$4.47$4.77
52-Week Range:
$2.94$6.53
Alvotech Stock (ALVO) Company Profile
Market Cap
Revenue
Net Income
Cash Flow
EPS